Peptide InjectionsAI
Limited evidence

Pe-22-28

Peptide therapy: benefits, side effects, cost and protocols

PE-22-28 is a synthetic peptide derived from the phosphodiesterase-4 (PDE4) inhibitor family that has been studied for nootropic and neuroprotective effects. It modulates cAMP signaling in the brain to potentially enhance memory consolidation and cognitive function.

ByChris Riley(CFA)|Updated

Sources: FDA / PubMed / ClinicalTrials.gov View

FDA status
Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
Evidence
Anecdotal

How Pe-22-28 works

Spadin analog that may modulate TREK-1 potassium channels, potentially offering rapid antidepressant-like effects.

Pe-22-28 questions

What is PE-22-28?

PE-22-28 is a synthetic peptide analog of Spadin, researched for its potential antidepressant and cognitive-enhancing effects.

How does PE-22-28 work?

Spadin analog that may modulate TREK-1 potassium channels, potentially offering rapid antidepressant-like effects.

Is PE-22-28 legal to buy?

PE-22-28 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.

Where can I buy PE-22-28?

PE-22-28 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.

What category does PE-22-28 belong to?

PE-22-28 is primarily classified as a cognitive enhancement peptide. Nootropic peptides researched for cognitive function, memory, focus, neuroprotection, and neurogenesis.

What are the research benefits of PE-22-28?

PE-22-28 has been studied for: Antidepressant research, Mood support, Cognitive enhancement. Spadin analog; mood and cognition research.

Pe-22-28 in the news

News aggregated via Google News. Inclusion does not imply endorsement.

Considering Pe-22-28?

The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.

Take the quiz